Life Tech to Present SOLiD, Single-Molecule Updates Next Month; Bets on Clinical Cancer Sequencing
January 12, 2010
Life Tech to Present SOLiD, Single-Molecule Updates Next Month; Bets on Clinical Cancer Sequencing
To illustrate the potential usefulness of next-gen sequencing in oncology, Lucier presented results from a study conducted at the Translational Genomics Research Institute in Phoenix, Ariz.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech's CE Research Business Picked Up in Q3; Company to Share Single-Molecule Results Next Year
October 27, 2009 / In Sequence - Ion Torrent Sales Contribute $13M to Life Tech's Q2 Top Line; Delays Hamper 5500 Revenue
August 2, 2011 / In Sequence - Ion Torrent PGM Sales Exceed Life Tech's Expectations in Q1 while SOLiD Sales Suffer
May 3, 2011 / In Sequence - Life Tech Reports Increase in CE Business for Research and Clinical Labs, Strong Growth in SOLiD Sales in Q2
August 3, 2010 / In Sequence - Double-Digit Growth in Next-Gen Sequencing Contributes to 14-Percent Q1 Revenue Boost for Life Tech
May 4, 2010 / In Sequence